Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated interferon alfa-2a plus adefovir for chronic hepatitis B genotype D
IRCT138711201155N4Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Mar 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2a, adefovir dipivoxil in Chronic Hepatitis B (CHB), sponsored by Guilan University of Medical Sciences. Started Mar 2009; status: completed.
02
Drugs
peginterferon alfa-2aadefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on IRCT138711201155N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138711201155N4.